Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fortress Biotech, Inc. Insider Profile
11 Followers
Fortress Biotech, Inc., Ten Percent Owner at Avenue Therapeutics, holds 3.55M shares in Avenue Therapeutics (Ticker: ATXI), holds 2.10M shares in Checkpoint Therapeutics (Ticker: CKPT), holds 22.63M shares in Mustang Bio (Ticker: MBIO).
Fortress Biotech, Inc. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Fortress Biotech, Inc. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Fortress Biotech, Inc.
Fortress Biotech, Inc.'s Trading History
Avenue Therapeutics
Apr 17, 2024
Ten Percent Owner
Uninformative Buy
―
$478.90K
Checkpoint Therapeutics
Mar 22, 2024
Ten Percent Owner
Uninformative Buy
―
$3.50M
Mustang Bio
Jan 06, 2023
Ten Percent Owner
Uninformative Buy
―
$8.69M
List of latest transactions for each holding click on a transaction to see Fortress Biotech, Inc.'s performance on stock
You May Also Like
Fortress Biotech, Inc. insider profile FAQ
What is the percentage of profitable transactions made by Fortress Biotech, Inc.?
The percentage of profitable transactions made by Fortress Biotech, Inc. is ―.
What is the average return per transaction made by Fortress Biotech, Inc.?
The average return per transaction made by Fortress Biotech, Inc. is ―.
What stocks does Fortress Biotech, Inc. hold?
Fortress Biotech, Inc. holds: ATXI, CKPT, MBIO stocks.
What was Fortress Biotech, Inc.’s latest transaction?
Fortress Biotech, Inc. latest transaction was an Uninformative Buy of ―.
What was Fortress Biotech, Inc.'s most profitable transaction?
Fortress Biotech, Inc.’s most profitable transaction was an Informative Buy of ATXI stock on September 12, 2023. The return on the trade was -82.90%.
What is Fortress Biotech, Inc.'s role in Avenue Therapeutics?
Fortress Biotech, Inc.'s role in Avenue Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.